Neurological Devices Panel of the Medical Devices Advisory Committee Meeting Announcement (March 23, 2012)

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2012-N-0001] Neurological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting AGENCY:  Food and Drug Administration, HHS. ACTION:  Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA).  The meeting will be…

RegenArouse: Recall

<!– –> <!– Page Last Updated: 02/13/2012 –> Page Last Updated: 02/13/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

Hand-held Dental X-Ray Units: FDA Safety Communication

<!– –> <!– Page Last Updated: 02/10/2012 –> Page Last Updated: 02/10/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

Wholistic Herbs, Inc. "Koff and Kold" and "Kold Sore" Spray: Recall – Non

[Posted 02/10/2012] AUDIENCE: Consumer ISSUE: Wholistic Herbs Inc. notified the public it is recalling all quantities of “Koff Kold” spray with herbal extract and “Kold Sore” spray with liquid sea mineral. “Koff Kold” spray with herbal extract is intended to be sprayed into the nose and throat for treatment of colds, flu, cough, stuffy nose,…

FDA Safety Communication: Illegal Sale of Potentially Unsafe Hand-held Dental X-Ray Units

Date Issued: Feb. 10, 2012 Audience: Health care providers including dentists, dental care professionals and veterinarians who have purchased or are considering purchasing a hand-held dental X-ray unit. Device: A small, hand-held device intended for dental X-ray examinations. Purpose: The FDA is issuing this communication to alert health care providers, including dentists, dental care professionals…

Comunicado de la FDA sobre la seguridad de los medicamentos: Nuevo factor de riesgo para la leucoencefalopatía multifocal progresiva (PML por sus siglas en inglés) relacionado con Tysabri (natalizumab)

Anuncio de seguridadInformación adicional para pacientesInformación adicional para profesionales de la saludResumen de datos Anuncio de seguridad El 20 de enero del 2012, la Administración de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en inglés) informó al público que ha identificado como factor de riesgo para la leucoencefalopatía multifocal progresiva (PML por…